Signal Transduction by a 5-HT2 Receptor: A Mechanistic Hypothesis from Molecular Dynamics Simulations of the Three-Dimensional Model of the Receptor Complexed to Ligands

Journal of Medicinal Chemistry

Volumn 36, Issue 7, 1993, Pages 934-938

  Zhang, Daqun ^a   Weinstein, Harel ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; MEMBRANE PROTEIN; SEROTONIN; SEROTONIN 2 RECEPTOR;

ARTICLE; CHEMICAL STRUCTURE; DRUG STRUCTURE; LIGAND BINDING; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TEMPERATURE; THERMODYNAMICS;

EID: 0027416441     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00059a021     Document Type: Editorial

References (61)

1. Dixon, R. A. F.; Sigal, I. S.; Candelore, M. R.; Register, R. B.; Scattergood, W.; Rands, E.; Strader, C. D. Structural features required for ligand binding to the beta-adrenergic receptor. EMBO J. 1987, 6, 3269–3275.
2. Strader, C. D.; Sigal, I. S.; Dixon, R. A. F. Structural basis of β-adrenergic receptor function. FASEB J. 1989, 3, 1825–1831.
3. Sanders-Bush, E. The Serotonin Receptors; Humana Press: Clifton, NJ, 1989.
4. Dohlman, H. G.; Thorner, J.; Caron, M. G.; Lefkowitz, R. J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 1991, 60, 653–688.
5. Strossberg, A. D. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur. J. Biochem. 1991, 196, 1–10.
6. Peroutka, S. J. Serotonin Receptor Subtypes; Wiley-Liss: New York, 1991; p 236.
7. Shih, J. C.; Yang, W.; Chen, K.; Gallaher, T. Molecular biology of serotonin (5-HT) receptors. Pharmacol. Biochem. Behav. 1991, 40, 1053–1058.
8. Gantz, I.; Del Valle, J.; Wang, L.-D.; Tashiro, T.; Munzert, G.; Guo, Y.-J.; Konda, Y.; Yamada, T. Molecular basis for the interaction of histamine with the histamine H2 receptor. J. Biol. Chem. 1992, 267, 20840–20843.
9. McCammon, J. A. Computer-aided molecular design. Science 1987, 238, 486–491.
10. Jensen, B.; Jorgensen, F. S.; Kofod, H. Frontiers in Drug Research: Crystallographic and Computational Methods; Munksgaard: Copenhagen, 1990; Vol. 28, p 417.
11. Weinstein, H.; Osman, R. Simulations of ligand-receptor interactions as guides for design. In Alfred Benzon Symposium 28; Munksgaard, Copenhagen, 1989; pp 169–182.
12. Weinstein, H.; Osman, R. On the structural and mechanistic basis of function, classification, and ligand design for 5-HT receptors. Neuropsychopharmacology 1990, 3, 397–409.
13. Weinstein, H.; Zhang, D. Receptor mechanisms at atomic resolution: New perspectives for drug design. Submitted for publication in J. Med. Chem.
14. Dahl, S. G.; Edvardsen, O.; Sylte, I. Molecular dynamics of dopamine at the D2 receptor. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 8111–8115.
15. Hibert, M. F.; Trumpp-Kallmeyer, S.; Bruinvels, A.; Hoflack, J. Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 1991, 40, 8–15.
16. Edvardsen, O.; Sylte, I.; Dahl, S. G. Molecular dynamics of serotonin and ritanserin interacting with the 5-HT2 receptor. Mol. Brain Res. 1992, 14, 166–178.
17. Lewell, X. Q. A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Design Discov. 1992, 9, 29–48.
18. MaloneyHuss, K.; Lybrand, T. P. Three-dimensional structure for the beta2 adrenergic receptor protein based on computer modeling studies. J. Mol. Biol. 1992, 225, 859–871.
19. Ijzerman, A. P.; Van Galen, P. J. M.; Jacobson, K. A. Molecular modeling of adenosine receptors. 1. The ligand binding site on the A1 receptor. Drug Design Discov. 1992, 9, 49–67.
20. Findlay, J.; Eliopoulos, E. Three-dimensional modelling of G protein-linked receptors. Trends Pharmacol. Sci. 1990, 11, 492–499.
21. Humblet, C.; Mirzadegan, T. Three-dimensional models of G-protein coupled receptors. Annu. Rep. Med. Chem. 1992, 27, 291–300.
22. Henderson, R.; Baldwin, J. M.; Ceska, T. A.; Zemlin, F.; Beckmann, E.; Downing, K. H. Model for the structure of Bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol. 1990, 213, 899–929.
23. Pardo, L.; Ballesteros, J. A.; Osman, R.; Weinstein, H. On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 4009–4012.
24. Ballesteros, J. A.; Weinstein, H. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. Biophys. J. 1992, 62, 107–109.
25. Trumpp-Kallmeyer, S.; Hoklack, J.; Bruinvels, A.; Hibert, M. Modeling of G-protein-coupled receptors: Application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992, 35, 3448–3462.
26. Weinstein, H.; Zhang, D.; Ballesteros, J. A. Hallucinogens acting at 5-HT receptors: Towards a mechanistic understanding at atomic resolution. In NIDA Research Monograph, Hallucinogens: An Update; Lin, G., Glennon, R. A., Eds.; National Institute on Drug Abuse: Washington, D.C., 1992; in press.
27. Costa, T.; Ogino, Y.; Munson, P. J.; Onaran, H. O.; Rodbard, D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: Thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 1992, 41, 549–560.
28. Pritchett, D. B.; Bach, A. W. J.; Wozny, M.; Taleb, O.; Dal Toso, R.; Shih, J. C.; Seeburg, P. H. Structure and functional expression of cloned rat serotonin 5HT-2 receptor. EMBO J. 1988, 7, 4135–4140.
29. Julius, D.; Huang, K. N.; LiveUi, T. J.; Axel, R.; Jessel, T. M. The 5HT2 receptor defines a family of structurally disctinct but functionally conserved serotonin receptors. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 928–932.
30. Hartig, P. R. Molecular biology of 5-HT receptors. Trends Pharmacol. Sci. 1989, 10, 64–69.
31. Hartig, P.; Kao, H.-T.; Macchi, M.; Adham, N.; Zgombick, J.; Weinshank, R.; Branchek, T. The molecular biology of serotonin receptors. Neuropsychopharmacology 1990, 3, 335–347.
32. Hen, R. Of mice and flies: Commonalities among 5-HT receptors. Trends Pharmacol. Sci. 1992, 13, 160–165.
33. Glennon, R. A.; Wetkaemper, R. B.; Bartyzel, P. Medicinal Chemistry of Serotonergic Agents. In Serotonin Receptor Subtypes: Basic and Clinical Aspects; Peroutka, S. J., Eds.; Wiley-Liss, Inc.: New York, 1991; Vol. 15; pp 19–64.
34. Weinstein, H.; Osman, R.; Mazurek, A. P. Simulations of molecular stereoelectronic mechanisms for the interaction of hallucinogens and indole derivatives at 5-HT receptors. In Stereoelectronic Aspects of Biomolecular Interactions; Naray-Szabo, G., Kaiman, S., Eds.; CRC Press: Boca Raton, FL, 1987; pp 199–210.
35. Weinstein, H.; Osman, R.; Mercier, G. In Problems of Drug Dependence; US-HHS, NIDA: NIDA Research Monograph 90, Proceedings of the 50th Annual Meeting, Maryland, 1988; pp 243–255.
36. von Heijne, G. Proline kinks in transmembrane alpha-helices. J. Mol. Biol. 1991, 218, 499–503.
37. Williams, K. A.; Deber, C. M. Proline residues in transmembrane helices: Structural or dynamic role? Biochemistry 1991, 30, 8919–8923.
38. Ballesteros, J. A.; Weinstein, H. The role of Pro/Hyp-kinks in determining the transmembrane helix length and gating mechanism of a Leu-zervamicin channel. Biophys. J. 1992, 62, 110–111.
39. Barlow, D. J.; Thornton, J. M. Helix geometry in proteins. J. Mol. Biol. 1988, 203, 601–619.
40. Chadwick, D. J.; Widdows, K. Protein Conformation: Ciba Foundation Symposium 161; John Wiley & Sons: New York, 1991; pp 269.
41. Piela, L.; Nemethy, G.; Scheraga, H. A. Pro-induced constraints in alpha-helices. Biopolymers 1987, 26, 1587–1600.
42. Rees, D. C.; DeAntonio, L.; Eisenberg, D. Hydrophobic organization of membrane proteins. Science 1989, 245, 510–513.
43. von Heijne, G.; Manoil, C. Membrane proteins: from sequence to structure. Prot. Eng. 1990, 4, 109–112.
44. von Heijne, G. Membrane protein structure prediction: Hydrophobicity analysis and the “positive inside” rule. J. Mol. Biol. 1992, 225, 487–494.
45. Kahn, T. W.; Engelman, D. M. Bacteriorhodopsin can be refolded from two independently stable tranmembrane helices and the complementary five-helix fragment. Biochemistry 1992, 31, 6144–6151.
46. Strader, C. D.; Dixon, R. A. F.; Cheung, A. H.; Candelore, M. R.; Blake, A. D.; Sigal, I. S. Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. J. Biol. Chem. 1987, 262, 16439–16443.
47. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathan, S.; Karplus, M. CHARMM: A program for macromolecular energy, minimization and dynamics calculations. J. Comput. Chem. 1983, 4, 187–217.
48. Brooks, C. L.; Karplus, M.; Pettitt, B. M. Proteins: A Theoretical Perspective of Dynamics, Structure, and their Thermodynamics; John Wiley & Sons: New York, 1988.
49. Liebman, M. N.; Venanzi, C. A.; Weinstein, H. Structural analysis of carboxypeptidase A and its complexes with inhibitors as a basis for modeling enzyme recognition and specificity. Biopolymers 1985, 24, 1721–1758.
50. Jahnig, F.; Endholm, O. Modeling of the structure of bacteriorhodopsin. J. Mol. Biol. 1992, 225, 837–850.
51. Weinstein, H.; Osman, R.; Topiol, S.; Green, J. P. Quantum chemical studies on molecular determinants of drug action. Ann. N. Y. Acad. Sci. 1981, 367, 434–451.
52. Reggio, P.; Weinstein, H.; Osman, R.; Topiol, S. Molecular determinants for binding of methylenedioxytryptamines at 5-HT/LSD receptors. Int. J. Quantum Chem. 1981, QBS8, 373–384.
53. Weinstein, H.; Osman, R.; Green, J. P.; Topiol, S. Electrostatic potentials as descriptors of molecular reactivity: The basis for some successful predictions of biological activity. In Chemical Applications of Atomic and Molecular Electrostatic Potentials; Politzer, P., Truhlar, D. G., Eds.; Plenum Press: New York, 1981; pp 309–323.
54. Mazurek, A. P.; Weinstein, H.; Osman, R.; Topiol, S.; Ebersole, B. J. Theoretical and experimental studies of drug-receptor interactions: Determinants for recognition of 5-HT analogs. Int. J. Quantum Chem. 1984, QBS11, 183–194.
55. Pollock, N. J.; Manelli, A. M.; Hutchins, C. W.; Steffey, M. E.; MacKenzie, R. G.; Frail, D. E. Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J. Biol. Chem. 1992, 267, 17780–17786.
56. Horstman, D. A.; Brandon, S.; Wilson, A. L.; Guyeer, C. A.; Gragoe, E. J.; Limbird, L. E. An aspartate conserved among G-protein receptors confers allosteric regulation of a2-adrenergic receptors by sodium. J. Biol. Chem. 1990, 265, 21590–21595.
57. Neve, K. A. Regulation of dopamine D2 receptors by sodium and pH. Mol. Pharm. 1991, 39, 570–578.
58. Chung, F.-Z.; Wang, C.-D.; Potter, P. C.; Venter, J. C.; Fraser, C. M. Site-directed mutagenesis and continuous expression of human β-adrenergic receptors. J. Biol. Chem. 1988, 263, 4052–4055.
59. Kjelsberg, M. A.; Cotecchia, S.; Ostrowski, J.; Caron, M. G.; Lefkowitz, R. J. Constitutive activation of the alpha1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 1992, 267, 1430–1433.
60. van Gunsteren, W. F.; Berendsen, H. J. C. Algorithms for macromolecular dynamics and constraint dynamics. J. Mol. Phys. 1977, 34, 1311–1327.
61. Reed, A. E.; Weinstock, R. B.; Weinhold, F. Natural population analysis. J. Chem. Phys. 1985, 83, 735–746.